{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:30:35Z","timestamp":1762086635574,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008979","name":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Endocrinologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008966","name":"Soci\u00e9t\u00e9 Francophone du Diab\u00e8te","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015613","name":"Centre hospitalier r\u00e9gional universitaire de Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ando.2024.01.009","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T12:11:53Z","timestamp":1707135113000},"page":"166-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-life experience with DPP4 inhibitors for graft dysfunction after human islet allotransplantation"],"prefix":"10.1016","volume":"85","author":[{"given":"Valentin","family":"Lericque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4910-2958","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9rique","family":"Defrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Kerr-Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-0463","authenticated-orcid":false,"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2024.01.009_bib0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ando.2021.03.006","article-title":"1921\u20132021: from insulin discovery to islet transplantation in type 1 diabetes","volume":"82","author":"Chetboun","year":"2021","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2024.01.009_bib0075","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11892-013-0402-z","article-title":"Use of glucagon-like peptide-1 agonists to improve islet graft performance","volume":"13","author":"Wang","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ando.2024.01.009_bib0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/db08-1101","article-title":"Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation","volume":"58","author":"Kim","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ando.2024.01.009_bib0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/MPA.0b013e318214832d","article-title":"Improved outcome of islet transplantation in partially pancreatectomized diabetic mice by inhibition of dipeptidyl peptidase-4 with sitagliptin","volume":"40","author":"Kim","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.ando.2024.01.009_bib0090","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41574-022-00735-x","article-title":"Glucagon receptor antagonists might stimulate \u03b2-cell expansion","volume":"18","author":"de Celis","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2024.01.009_bib0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12020-013-9984-0","article-title":"Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats","volume":"45","author":"Hu","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2024.01.009_bib0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.stemcr.2015.02.011","article-title":"Treating diet-induced diabetes and obesity with human embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs","volume":"4","author":"Bruin","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.ando.2024.01.009_bib0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/ajt.13979","article-title":"Sitagliptin treatment after total pancreatectomy with islet autotransplantation: a randomized, placebo-controlled study","volume":"17","author":"Bellin","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ando.2024.01.009_bib0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/dme.13131","article-title":"Sitagliptin plus pantoprazole can restore but not maintain insulin independence after clinical islet transplantation: results of a pilot study","volume":"34","author":"Senior","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.ando.2024.01.009_bib0115","doi-asserted-by":"crossref","first-page":"e2237606","DOI":"10.1001\/jamanetworkopen.2022.37606","article-title":"Comparative effectiveness of empagliflozin vs liraglutide or sitagliptin in older adults with diverse patient characteristics","volume":"5","author":"Htoo","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ando.2024.01.009_bib0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/JOE-20-0315","article-title":"Combined use of GABA and sitagliptin promotes human \u03b2-cell proliferation and reduces apoptosis","volume":"248","author":"Liu","year":"2021","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.009_bib0125","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1172\/JCI32959","article-title":"Recovery from diabetes in mice by beta cell regeneration","volume":"117","author":"Nir","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2024.01.009_bib0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S2213-8587(14)70115-9","article-title":"Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial","volume":"2","author":"Griffin","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662400009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662400009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:25:34Z","timestamp":1762086334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000342662400009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S000342662400009X"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2024.01.009","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life experience with DPP4 inhibitors for graft dysfunction after human islet allotransplantation","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2024.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}